# Raltegravir in the Swiss HIV Cohort Study

> **NCT00904644** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 200 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Raltegravir

## Key facts

- **NCT ID:** NCT00904644
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2011-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2018-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904644, "Raltegravir in the Swiss HIV Cohort Study". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00904644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*